Menopausal hormone therapies: Their effect on mammographic density and breast cancer risk

By Santen Richard  

Gynecological Endocrinology, Vol. 21, Iss. 1, 2005-07 ,pp. : 12-16

Informa Healthcare

Access to resources Recommend Favorite

Paternal age and adverse birth outcomes: teenager or 40, who is at risk?

By Chen Xi-Kuan   Wen Shi Wu   Krewski Daniel   Fleming Nathalie   Yang Qiuying   Walker Mark C.  

Human Reproduction, Vol. 23, Iss. 6, 2008-06 ,pp. : 1290-1296

Oxford University Press

Access to resources Recommend Favorite

Comparative vascular effects of hormone replacement therapy and raloxifene in women at increased cardiovascular risk

By Cerquetani E   Vitale C   Mercuro G   Fini M   Zoncu S   Rosano GMC  

Gynecological Endocrinology, Vol. 18, Iss. 6, 2004-06 ,pp. : 291-298

Informa Healthcare

Access to resources Recommend Favorite

Clinician-Assessed Poor Compliance Identifies Adults with Severe Asthma Who Are at Risk of Adverse Outcomes

By Smith Jane   Mildenhall Sue   Noble Michael   Mugford Miranda   Shepstone Lee   Harrison Brian  

Journal of Asthma, Vol. 42, Iss. 6, 2005-07 ,pp. : 437-445

Informa Healthcare

Access to resources Recommend Favorite

Development of low-dose reproductive hormone therapies in China

By Ge Qinsheng   Tian Qinjie   Tseng Hung   Naftolin Frederick  

Gynecological Endocrinology, Vol. 22, Iss. 11, 2006-11 ,pp. : 636-645

Informa Healthcare

Access to resources Recommend Favorite